Gene-modified mesenchymal stem cells as a potential treatment for Huntington's disease: preparing for a planned Phase I clinical trial
Available to view on demand. The UC Davis research team present an update on preclinical development of the cell-gene therapy product and the planned Phase I trial.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.